National Geographic Logo - Home
  • Newsletters
  • Subscribe
Here's what we know about the BA.2 Omicron subvariant driving a new COVID-19 wave
Here's what we know about the BA.2 Omicron subvariant driving a new COVID-19 waveApril 25, 2022 – BA.2 infections aren’t as mild as once thought and even newer versions of Omicron are circulating and spreading fast
How Merck's antiviral pill could change the game for COVID-19
How Merck's antiviral pill could change the game for COVID-19October 01, 2021 – Promising results from clinical trials suggest that the drug may become the first at-home treatment cleared for use by the FDA.
Photos show the first 2 years of a world transformed by COVID-19
Photos show the first 2 years of a world transformed by COVID-19March 03, 2022 – Our photographers bore witness to the ways the world has coped—and changed—since the pandemic began.
Omicron has meant even more adjustments for kids. Here’s how parents can help.
Omicron has meant even more adjustments for kids. Here’s how parents can help.January 24, 2022 – We’ve all heard how resilient kids have been throughout the pandemic. But 2022 is all about adaptability—a skill they’ll need later in life.
FDA authorizes Pfizer booster doses for teens ages 16 and 17
FDA authorizes Pfizer booster doses for teens ages 16 and 17December 09, 2021 – Unlike the mix-and-match approach approved for older populations, the agency only authorized the shots for teens who originally received Pfizer’s vaccine.
Is a 'twindemic' of flu and COVID-19 about to hit the U.S.?
Is a 'twindemic' of flu and COVID-19 about to hit the U.S.?October 13, 2021 – Experts warn that the U.S. is ripe for a severe influenza outbreak in the coming months, making vaccination against both diseases more important than ever.
FDA authorizes Merck’s COVID-19 antiviral pill
FDA authorizes Merck’s COVID-19 antiviral pillDecember 23, 2021 – The decision came a day after Pfizer’s antiviral drug became the first of its kind to be authorized in the U.S.
FDA authorizes Pfizer’s COVID-19 antiviral pill
FDA authorizes Pfizer’s COVID-19 antiviral pillDecember 22, 2021 – The treatment is the first of its kind to be authorized in the U.S. It will be available for adults and children older than 12 who are at risk of severe disease.
Omicron is dodging the immune system—but boosters show promising signs
Omicron is dodging the immune system—but boosters show promising signsDecember 10, 2021 – Initial data on the new variant have experts worried about its ability to spread rapidly. But vaccine boosters still seem to be effective, as do some monoclonal antibody therapies.
U.S. confirms first case of Omicron variant in California
U.S. confirms first case of Omicron variant in CaliforniaDecember 01, 2021 – The White House says the patient was diagnosed after traveling from South Africa to San Francisco and is experiencing mild symptoms.
COVID-19’s hidden, heartbreaking toll: millions of orphaned children
COVID-19’s hidden, heartbreaking toll: millions of orphaned childrenMay 06, 2022 – An estimated 10.4 million children have lost a parent or caregiver, putting them at higher risk for poverty and every major cause of death—but it doesn’t have to end in catastrophe.
'Flurona' explained: What to expect from COVID-19 and flu co-infections
'Flurona' explained: What to expect from COVID-19 and flu co-infectionsFebruary 11, 2022 – A new study shows that such cases are still extremely rare and mostly occur in relatively young, healthy patients.
Pfizer says its vaccine is 90.7 percent effective in kids ages 5 to 11
Pfizer says its vaccine is 90.7 percent effective in kids ages 5 to 11October 22, 2021 – Here’s the latest news on COVID-19 vaccine rollout.
Could viruses cause Alzheimer's? COVID-19 brain studies offer new clues.
Could viruses cause Alzheimer's? COVID-19 brain studies offer new clues.January 14, 2022 – The diseases share some surprising similarities, and experts now think studying COVID-19 patients' brains could lead to better treatments for both conditions.
CDC clears the way for Moderna and Johnson & Johnson boosters
CDC clears the way for Moderna and Johnson & Johnson boostersOctober 21, 2021 – Here’s the latest news on COVID-19 vaccine rollout.
Why is it so hard to compensate people for serious vaccine side effects?
Why is it so hard to compensate people for serious vaccine side effects?March 11, 2022 – Though very rare, complications from shots can shatter lives and trust. Now the federal programs designed to help them are struggling with COVID-19.
Previous
  • 1
  • 2
  • 3
  • 4
  • 5
  • ...
  • 57
Next

Legal

  • Terms of Use
  • Privacy Policy
  • Your US State Privacy Rights
  • Children's Online Privacy Policy
  • Interest-Based Ads
  • About Nielsen Measurement
  • Do Not Sell or Share My Personal Information

Our Sites

  • Nat Geo Home
  • Attend a Live Event
  • Book a Trip
  • Buy Maps
  • Inspire Your Kids
  • Shop Nat Geo
  • Visit the D.C. Museum
  • Watch TV
  • Learn About Our Impact
  • Support our Mission
  • Nat Geo Partners
  • Masthead
  • Press Room
  • Advertise With Us

Join Us

  • Subscribe
  • Customer Service
  • Renew Subscription
  • Manage Your Subscription
  • Work at NatGeo
  • Signup for Our Newsletters
  • Contribute to Protect the Planet
  • Pitch a Story

Follow us


National Geographic Logo - Home

Copyright © 1996-2015 National Geographic SocietyCopyright © 2015-2023 National Geographic Partners, LLC. All rights reserved